https://www.healio.com/news/primary-care/20230217/top-in-rheumatology-covid19-vaccination-in-rituximab-users-familial-mediterranean-fever
Research has shown that breakthrough SARS-CoV-2 infections are common among patients using rituximab. However, a new study found that few rituximab users who are fully vaccinated against COVID-19 develop severe symptoms. The results “offer assurance to …
Create an account or login to join the discussion